Near-Infrared Polymeric Nanoparticles with High Content of Cyanine for Bimodal Imaging and Photothermal Therapy
Source abstract
Abstract
The discovery and synthesis of theranostic nanomedicines with high loading of imaging and therapeutic agents is challenging. In this work, a polymer assembling strategy was used to make nanoparticles with exceptionally high loading of theranostic agent. As an example, poly(heptamethine) was synthesized via multicomponent Passerini reaction, and then assembled into nanoparticles in the presence of poly(ethylene glycol)2k-block-poly(d,l-lactide)2k (PEG-PLA) with high heptamethine loading (>50%). The formed nanoparticles could be used for bimodal bioimaging and photothermal therapy. The bimodal bioimaging provided complementary message about biodistribution, and photothermal treatment inhibited the growth of cervical carcinoma upon laser irradiation. This assembly of polymers formed by imaging and therapeutic agents opens new possibilities for the construction of multifunctional nanomedicines.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 5625 Renmin Street, Changchun, Jilin 130022, P. R. China
University of Chinese Academy of Sciences, Beijing 100049, P. R. China
College of Environmental and Chemical Engineering, Yanshan University, Qinhuangdao 060004, P.R. China
Funding
National Natural Science Foundation of China
References (42)
Show source-provided references
1. 10.1016/j.biomaterials.2011.06.02410.1016/j.biomaterials.2011.06.024 ↗
2. 10.1021/acsami.6b0132010.1021/acsami.6b01320 ↗
3. 10.1038/nphoton.2015.2910.1038/nphoton.2015.29 ↗
4. 10.1021/acsami.5b1240010.1021/acsami.5b12400 ↗
5. 10.1021/am301301f10.1021/am301301f ↗
6. 10.1021/acsami.5b0626510.1021/acsami.5b06265 ↗
7. 10.1021/am500761x10.1021/am500761x ↗
8. 10.1021/am500258510.1021/am5002585 ↗
9. 10.1021/cr500314d10.1021/cr500314d ↗
10. 10.1146/annurev-bioeng-071812-15240910.1146/annurev-bioeng-071812-152409 ↗
11. 10.1038/nm.272110.1038/nm.2721 ↗
12. 10.1021/nn506361310.1021/nn5063613 ↗
13. 10.1021/acsnano.5b0217210.1021/acsnano.5b02172 ↗
14. 10.1002/anie.20110144710.1002/anie.201101447 ↗
15. 10.1002/ange.20140951910.1002/ange.201409519 ↗
16. 10.1021/acs.chemrev.5b0013510.1021/acs.chemrev.5b00135 ↗
17. 10.1039/C4CS00014E10.1039/C4CS00014E ↗
18. 10.1002/adfm.20130104510.1002/adfm.201301045 ↗
19. 10.1039/c2py20240a10.1039/c2py20240a ↗
20. 10.1016/j.biomaterials.2012.11.05710.1016/j.biomaterials.2012.11.057 ↗
21. 10.1016/j.biomaterials.2014.07.06210.1016/j.biomaterials.2014.07.062 ↗
22. 10.1002/jso.2194310.1002/jso.21943 ↗
23. 10.1007/s00595-015-1158-710.1007/s00595-015-1158-7 ↗
24. 10.1007/s00268-014-2911-610.1007/s00268-014-2911-6 ↗
25. 10.1016/j.biomaterials.2014.06.01310.1016/j.biomaterials.2014.06.013 ↗
26. 10.1016/j.biomaterials.2011.11.08110.1016/j.biomaterials.2011.11.081 ↗
27. 10.1021/nn506238610.1021/nn5062386 ↗
28. 10.1039/C5SC03707G10.1039/C5SC03707G ↗
29. 10.1021/ja513034e10.1021/ja513034e ↗
30. 10.1021/ja111300310.1021/ja1113003 ↗
31. 10.1039/c3cc44557g10.1039/c3cc44557g ↗
32. 10.1016/j.colsurfb.2014.12.03010.1016/j.colsurfb.2014.12.030 ↗
33. 10.1039/c4ra02666g10.1039/c4ra02666g ↗
34. 10.1016/j.colsurfb.2015.09.02010.1016/j.colsurfb.2015.09.020 ↗
35. 10.1002/anie.20141183310.1002/anie.201411833 ↗
36. 10.1039/C4RA09735A10.1039/C4RA09735A ↗
37. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
38. 10.1038/nrclinonc.2013.12310.1038/nrclinonc.2013.123 ↗
39. 10.1038/nrc367210.1038/nrc3672 ↗
40. Overgaard J. · Cancer Res. · 1979 · 39 · 3248
41. 10.1111/j.1751-1097.1991.tb09897.x10.1111/j.1751-1097.1991.tb09897.x ↗
42. 10.1002/adma.20120468310.1002/adma.201204683 ↗